These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9030468)

  • 41. [Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].
    Pár G; Berki T; Pálinkás L; Balogh P; Szereday L; Halász M; Szekeres-Barthó J; Miseta A; Hegedus G; Mózsik G; Hunyady B; Pár A
    Orv Hetil; 2006 Apr; 147(13):591-600. PubMed ID: 16623441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Management of chronic hepatitis B].
    Telegdy L
    Orv Hetil; 1997 Jun; 138(22 Suppl 1):1462-5. PubMed ID: 9221375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 44. Interferon-alpha increases prostaglandin E2 production by cultured liver biopsy in patients with chronic viral hepatitis: can non-steroidal anti-inflammatory drugs improve the therapeutic response to interferon?
    Andreone P; Cursaro C; Gasbarrini G
    J Hepatol; 1993 Sep; 19(2):228-31. PubMed ID: 8301055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment with interferon alpha of hemophiliacs with chronic hepatitis C].
    Aguilar Franco C; Lucía Cuesta JF; Simón Marco MA
    Rev Clin Esp; 1996 Oct; 196(10):727-8. PubMed ID: 9005483
    [No Abstract]   [Full Text] [Related]  

  • 46. Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus.
    Yu JW; Sun LJ; Zhao YH; Kang P; Gao J; Li SC
    Liver Int; 2009 Nov; 29(10):1485-93. PubMed ID: 19602134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Interferon therapy in chronic active viral hepatitis].
    Lengyel G; Fehér J
    Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy.
    Chung RT; Kim AY; Polsky B
    Antivir Chem Chemother; 2001; 12 Suppl 1():73-91. PubMed ID: 11594692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon therapy of chronic hepatitis B.
    Brunetto MR; Bonino F
    Intervirology; 2014; 57(3-4):163-70. PubMed ID: 25034484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental studies of oxymatrine and its mechanisms of action in hepatitis B and C viral infections.
    Wu XN; Wang GJ
    Chin J Dig Dis; 2004; 5(1):12-6. PubMed ID: 15612666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
    Hung CH; Lu SN; Wang JH; Hu TH; Chen CH; Huang CM; Lee CM
    Antivir Ther; 2011; 16(7):959-68. PubMed ID: 22024511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. De-immunized and Functional Therapeutic (DeFT) versions of a long lasting recombinant alpha interferon for antiviral therapy.
    Mufarrege EF; Giorgetti S; Etcheverrigaray M; Terry F; Martin W; De Groot AS
    Clin Immunol; 2017 Mar; 176():31-41. PubMed ID: 28089609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Interferon is useful in the treatment of chronic hepatitis B].
    Vuoristo M
    Duodecim; 1991; 107(13):1087-90. PubMed ID: 1365335
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
    Chu CJ; Lee SD
    J Gastroenterol Hepatol; 2008 Apr; 23(4):512-20. PubMed ID: 18397482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b.
    Molloy PJ; Azzouz M; Van Thiel DH
    Am Fam Physician; 1996 Oct; 54(5):1598-605. PubMed ID: 8857782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis C virus eradication followed by HBeAg to anti-HBe seroconversion after pegylated interferon-alpha2b plus ribavirin treatment in a patient with hepatitis B and C coinfection.
    Rautou PE; Asselah T; Saadoun D; Martinot M; Valla D; Marcellin P
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):1019-22. PubMed ID: 16894318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(5):457-68. PubMed ID: 17147054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C.
    Umemura T; Alter HJ; Tanaka E; Orii K; Yeo AE; Shih JW; Matsumoto A; Yoshizawa K; Kiyosawa K
    Hepatology; 2002 Apr; 35(4):953-9. PubMed ID: 11915044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.